Journal Title
Translational Oncology

TRANSL ONCOL

ISSN / eISSN
1936-5233 / 1936-5233
Aims and Scope
Translational Oncology publishes the results of novel research investigations which bridge the laboratory and clinical settings including risk assessment, cellular and molecular characterization, prevention, detection, diagnosis and treatment of human cancers with the overall goal of improving the clinical care of oncology patients. Translational Oncology will publish laboratory studies of novel therapeutic interventions as well as clinical trials which evaluate new treatment paradigms for cancer. Peer reviewed manuscript types include Original Reports, Reviews and Editorials.
Subject Area

ONCOLOGY

CiteScore
7.20 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Oncology Q2 #95/366
Medicine - Cancer Research Q2 #87/214
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2023) Quartile
ONCOLOGY - SCIE Q2
H-index
41
Country/Area of Publication
UNITED STATES
Publisher
Neoplasia Press
Publication Frequency
Quarterly
Year Publication Started
2007
Annual Article Volume
305
Open Access
YES
Contact
NEOPLASIA PRESS, 1150 W MEDICAL CENTER DR, MSRB III, RM 9303, ANN ARBOR, USA, MI, 48109-0648
Verified Reviews
Note: Verified reviews are sourced from across review platforms and social media globally.
Submitted for four days and was directly accepted, isn't it a loss?
2022-02-15
Indeed, it is a loss. Perhaps we can aim for a higher score.
2022-07-06

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started